Nature Medicine
10, 1251 - 1256 (2004)
Published online: 24 October 2004; | doi:10.1038/nm1125
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-lin Kuo, Anna Lapuk, Kyosuke Yamada, Nelly Auersperg, Jinsong Liu, Karen Smith-McCune, Karen H Lu, David Fishman, Joe W Gray
& Gordon B MillsSupplementary Fig. 1 (pdf 17K)
RAB25 gene expression is associated with decreased overall survival in stage I−IV serous epithelial ovarian cancer patients. Supplementary Fig. 2 (pdf 18K)
RAB25 gene expression is associated with decreased disease free period in breast cancer patients, using data acquired from the Stanford breast cancer data set19. Supplementary Fig. 3 (pdf 30K)
Effect of RAB25 stable expression on cell proliferation in 1% or 10% fetal bovine serum containing media. Supplementary Fig. 4 (pdf 162K)
Knock down of RAB25 mRNA expression by RNA interference (RNAi) decreases cell number in A2780, OVCAR3, MCF-7 and in RAB25 stable transfected A2780 cells.
|
